Efficacy and safety of low dose QMF149 (150/80 microgram) compared with MF Twisthaler® in patients with asthma

Update Il y a 4 ans
Reference: EUCTR2016-000472-22

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to demonstrate the superiority of QMF149 150/80 microgram o.d. (in the evening) delivered via Concept1 compared with MF 200 microgram o.d. (in the evening) delivered via Twisthaler® in terms of trough FEV1 after 12 weeks of treatment in adults and adolescents.


Inclusion criteria

  • poorly (ie inadequately)controlled asthma patients